Goldman Sachs’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.37M | Buy |
|
|||||
|
2025
Q1 | $4.78M | Buy |
|
|||||
|
2024
Q4 | $7.42M | Buy |
|
|||||
|
2024
Q3 | $8.25M | Sell |
|
|||||
|
2024
Q2 | $9.03M | Buy |
|
|||||
|
2024
Q1 | $7.4M | Buy |
|
|||||
|
2023
Q4 | $4.67M | Hold |
|
|||||
|
2023
Q3 | $2.61M | Buy |
|
|||||
|
2023
Q2 | $2.62M | Sell |
|
|||||
|
2023
Q1 | $1.6M | Sell |
|
|||||
|
2022
Q4 | $1.72M | Buy |
|
|||||
|
2022
Q3 | $611K | Sell |
|
|||||
|
2022
Q2 | $804K | Buy |
|
|||||
|
2022
Q1 | $801K | Buy |
|
|||||
|
2021
Q4 | $1.14M | Buy |
|